Overview

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Status:
Unknown status

Trial end date:
2013-06-01

Target enrollment:

Participant gender:

Summary

Evaluate the safety and efficacy of Peginterferon alfa-2a following Entecavir compared with Peginterferon alfa-2a monotherapy in patient with HBeAg positive chronic hepatitis B. - Increased HBeAg seroconversion rate - Increased HBsAg loss rate - To define the best treatment condition for chronic HBV hepatitis patients

Phase:

Phase 3

Details

Lead Sponsor:

Hanyang University

Collaborator:

Roche Pharma AG

Treatments:

Entecavir
Interferon-alpha
Interferons
Peginterferon alfa-2a